Address: Oxfordlaan 70, 6229 EV Maastricht, Netherlands
Tel: + 31-43-35 09910
Web: http://www.pharmacell.nl/
PharmaCell provides contract services in the area of human cell & tissue banking & culturing as well as human cell line development and manufacturing of (bio) pharmaceuticals. Next to a GMP license, PharmaCell is the only commercial company in The Netherlands to hold an official license as Registered Tissue Establishment.
PharmaCell is also actively engaged in Research & Development work, both on behalf of some of its customers as well as in research consortia together with Universities, Academic Hospitals and other (bio)tech companies.
PharmaCell is located in the Biopartner Center Maastricht and, therefore, can take advantage of an extensive network to mediate in R&D, financing and housing requirements of clients. Close cooperation with Maastricht University and the associated Academic Hospital gives PharmaCell the unique capability to provide support and/or partnership to R&D companies to bring new products from the lab into the clinic.
PharmaCell offers fully integrated solutions for bio therapeutic proteins and (autologous and allogeneic) cell & tissue therapies, with established competencies which cover the full range of preclinical and clinical services for cell based biopharmaceuticals and therapies, including cell line development, cell banking, cell line characterization, process development and scale-up, custom cGMP manufacturing, lot release, stability testing and final product formulation and fill & finish. PharmaCell offers storage and distribution of Clinical Trail Materials including cell products and tissues and can also coordinate all logistics for autologous cell & tissue therapies throughout the European Union.
Our Maastricht facility was GMP certified in 2006 and in 2007 PharmaCell was granted an official licence as a Registered Tissue Establishment; the only company to hold such a license in The Netherlands.
PharmaCell operates a state-of-the art cGMP facility situated adjacent to the Maastricht University Hospital and within 15 minutes from both the German and Belgian border. Several airports are located close to Maastricht. The facility covers 250 square meters of clean room, classes A, B, C and D. (Classes 100 / 10,000 / 100,000), 180 square meters of R&D and QC laboratories including cryopreservation area.
All our customers have a single point of contact for the management of their project.
Paul Korte, General Manager for Janssen in the Netherlands, highlights the strategic move and leadership position taken up by Janssen in the oncology field, and calls on Dutch healthcare stakeholders…
In an exclusive interview, the Vice President of Philips Research explains the key to continuous evolution, improving healthcare stakeholder relations, and fostering “Open Innovation.” You have been Vice President of…
Healthcare is moving towards an increased level of personalization and active participation of the patient in the decision-making process. Roland van Esch, General Manager of Zimmer Biomet Netherlands, shares his…
Teva Benelux and Nordics’ GM lifts the lid on how the company has grown to become the market leader in the Netherlands. Looking at Teva’s activities, your market leader position in…
Takeda’s goal is to become a trusted and reliable partner in the healthcare system by better understanding patients’ needs. Aarnoud Overkamp, general manager of the Dutch subsidiary, shares his perspective…
In many aspects, 2016 truly marks the dawn of a new era for Toshiba Medical Systems. Lo Wuite (LW), General Manager Managed Equipment Services (MES) Europe, and Dick Blesing (DB),…
DHL Supply Chain Benelux understands the challenges life sciences companies face and has developed solutions to help overcome them. The Vice President and Commercial Director discuss how the services of…
Yvonne van Rooy, president of the NVZ, explains the patient’s increasing role as a partner in Dutch healthcare and how greater investment in ICT is needed for the patient to fulfill this role. She further discusses…
After having successfully acquired its first dialysis center in the Netherlands, Fresenius Medical Care, the market leader for kidney failure products and services, is looking to develop more partnerships with…
Ad Schuurman of the National Health Care Institute of the Netherlands (“Zorginstituut”) explains the main missions and mandates of this organization with regards to the basic insurance package covering all Dutch citizens,…
Kees Smaling, Managing Director of Siemens Healthcare, which recently completed its first Dutch (and European) hospital financing, explains the strategic thinking that sustains Siemens’ shift to become a more comprehensive…
DB Schenker’s Bart Coenen (BC) and Vincent Coolen (VC) explain the company’s Vision 2020 and talk about the benefits for pharma companies of outsourcing their supply chain. In 2013, DB…
See our Cookie Privacy Policy Here
